Gynaecological health startup Daye fund-raising
26 October 2022U.K.-based gynaecological health startup Daye, which is known for having invented the CBD tampon that is now used by over…Vivalto Sante goes international with expansion in
8 July 2022Candesic's Marc Kitten was quoted in the Healthcare Business International. He commented on the international expansion of Vivalto Sante, the…
Tackling the healthcare staffing crisis- new opportunities and new ways of working
11 March 2022Post pandemic the ONS highlight a decrease in unemployment, which is good news. But what is the impact on the…Voyage Care bought by Kuwaiti sovereign fund
21 January 2022Candesic's Dr Leonid Shapiro was quoted in the Healthcare Business International. He commented on the acquisition of Voyage Care by Wren House Infrastructure.…Private health groups to help NHS England deal with Omicron surge
14 January 2022In a Candesic analysis for the Financial Times, our consultants found that more hip and knee replacements were delivered in private health facilities…
NHS England questions cost of private hospital Covid deal
14 January 2022Financial Times spoke to Candesic's Dr Leonid Shapiro to get some insights about the real value of a three-month deal struck between…Keeping the nation moving – hip and knee replacement in the independent sector
10 January 2022Omicron and elective care lists have something in common – both are growing out of control. Here Candesic discuss how…Omicron pressure making outsourcing to for-profits increasingly essential
6 January 2022Candesic's Dr Leonid Shapiro was quoted in the Healthcare Business International. He commented about the Covid patients treated in the private…Reshaping cancer diagnosis and care pathways in the UK
5 October 2021A new generation of highly predictive biomarkers are being developed and launched to revolutionise the diagnosis and prognosis of cancer.…Private hospitals overtake NHS for hip and knee replacements
4 October 2021Candesic' analysis of hip and knee replacements have been quoted in the Financial Times.
